What is the Connection Study?A Connection to Tomorrow’s Hope

What is the Connection Study?

The Connection Study is a Phase 3 (late-stage) clinical study of 525 patients to test the effects of Dimebon in patients with Alzheimer’s disease. The goal of the Connection Study is to determine if Dimebon safely improves cognition (thinking and awareness), memory, daily functioning, behavior, and the ability to care for oneself. The Connection Study will also look at how Dimebon affects the lives of people caring for patients who are taking the medicine.

What is Dimebon?

Dimebon is an oral medication that is being tested as a potential treatment for Alzheimer’s disease. Currently, 5 prescription drugs are approved in the United States to treat Alzheimer’s disease. Dimebon works differently than any of these Alzheimer’s disease treatments.

Join the Connection Study

Do you or does someone you care about have Alzheimer’s? If so, please consider taking part in this research study. These 3 easy steps are all it takes to get started:

  1. 1 Check if there is a study site in your area.
  2. 2 Check the study requirements.
  3. 3 Call the toll-free number 877-888-6386 once you have completed steps 1 and 2.

It is important to check study locations and understand the entry requirements
before discussing the Connection Study with a physician.